GTX (GTXI) Reports Two POWER Trials Failed to Meet co-Primary Endpoints
- Wall St set to open lower as Meta Platforms, economic data weigh
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil steady as US demand concerns balance Middle East conflict risks
- Yen at multi-decade lows, dollar drops before US data
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Crude Inventory Declined 6.4 Million Barrels Last Week
- Meta Platforms, IBM, Caterpillar fall premarket; American Airlines, Chipotle rise
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
Stifel Nicolaus Downgrades GTX Inc. (GTXI) to Hold
August 20, 2013 7:10 AM EDTStifel Nicolaus downgraded GTX Inc. (NASDAQ: GTXI) from Buy to Hold.
For an analyst ratings summary and ratings history on GTX Inc. click here. For more ratings news on GTX Inc. click here.
Shares of GTX Inc. closed at $1.43 yesterday, with a 52 week range of $1.31-$7.24.... More
Jefferies Downgrades GTX Inc. (GTXI) to Hold
August 19, 2013 1:28 PM EDTJefferies downgraded GTX Inc. (NASDAQ: GTXI) from Buy to Hold with a price target of $1.50.
For an analyst ratings summary and ratings history on GTX Inc. click here. For more ratings news on GTX Inc. click here.
Shares of GTX Inc. closed at $4.15 yesterday, with a 52 week range of $3.39-$7.24.... More
Wedbush Downgrades GTX Inc. (GTXI) to Neutral
August 19, 2013 1:00 PM EDTWedbush downgraded GTX Inc. (NASDAQ: GTXI) from Outperform to Neutral with a price target of $2.00 (from $9.00). This morning GTX, Inc. (Nasdaq: GTXI) announced results of its two Phase 3 enobosarm clinical trials, the POWER trials, in patients with non-small cell lung... More
GTX, Inc. (GTXI) trading halted with news pending
August 19, 2013 7:56 AM EDTGTX, Inc. (NASDAQ: GTXI) trading halted with news pending.... More